FDA, CDC Coordinating On COVID-19 Vaccine Postmarket Monitoring

By Beth Wang / August 28, 2020 at 7:00 PM
FDA and the Centers for Disease Control and Prevention will conduct “heightened safety monitoring” for any COVID-19 vaccine that comes to market either through emergency use authorization or full licensure, CDC Director Robert Redfield said during a press call Friday (Aug. 28). Everyone who gets a vaccine will be tracked for side effects, and if the data show long-term side effects, the vaccine will be pulled from the market, Paul Mango, HHS deputy chief of staff for policy, added. CDC’s...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.